myelodysplastic syndromes (MDS) | Page 170 | Aplastic Anemia & MDS International Foundation Return to top.

myelodysplastic syndromes (MDS)

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

Author(s): 
Tiu RV, Gondek LP, O'Keefe CL, Elson P, Huh J, Mohamedali A, Kulasekararaj A, Advani AS, Paquette R, List AF, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP
Primary Author: 
Tiu RV
Journal Title: 
Blood
Original Publication Date: 
Feb 2011

Single nucleotide polymorphism arrays (SNP-As) have emerged as an important tool in the identification of chromosomal defects undetected

Bone Marrow Disease(s): 

Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.

Author(s): 
Delforge M, Selleslag D, Triffet A, Mineur P, Bries G, Graux C, Trullemans F, Macdonald K, Abraham I, Pluymers W, Ravoet C.
Primary Author: 
Delforge M
Journal Title: 
Ann Hematol
Original Publication Date: 
Feb 2011

Transfusion dependency and

Bone Marrow Disease(s): 

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.

Author(s): 
Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF
Primary Author: 
Sokol L
Journal Title: 
Br J Haematol
Original Publication Date: 
Feb 2011

The

Bone Marrow Disease(s): 
Share with addtoany.com.